1[1]Giacchetti S, Perpoint B, Zidani R,et al. Phase Ⅲ multicentric randomized trial of oxaliplatin added to chronomodulated fluorouracio-leucovorin as first-line treatment of metastatic colorectal cancer[J]. J Clin Oncol,2000,18:136-147.
2[2]A.de Gramont, Figer A, Seymour M,et al,Leucovorin and fluorouracil with or without oxaliplatin ad first-time treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18:2938-2947.
3[3]Bismuth H, Adam R, Levi F,et al. Resection of nonresectable liver metastases for colorectal cancer after neoadjuvant chemotherapy[J].Ann Surgery, 1996,4:509-522.
4[4]Joanne Graham,Mohamed Muhsin,Peter Kirkpatrick,Fresh from the pipeline ,Oxaliplatin[J].Nature Reviews Drug Discovery,2004,3:11-12.
5[5]Rixe O, Ortuzar W, Alvarez M,et al.Oxaliplatin,tetraplatin,cisplatin and carboplatin:spectrum of activity in drug resistant cell lines and in the cell lines of the National Cancer Institures anti cancer drug screen panel[J].Biochem Pharmacol,1996,52:1855-1865.
6[6]Soulie P, Raymond E, Misset J. Oxaliplatin: Update on a active and safe DACH platinum complex. In: Pinedo H, Schornagel J (eds). Platinum and other metal coordination compounds in cancer chemotherapy[M]. New York: Plenum Press, 1996. 165-174.
7[7]Mariani G, Ganone O,Granetto C,et al. Oxaliplatin induced neuropathy:could gabapentin be the answer[C]. Proc,ASCO,2000. 2397.
8[8]Wiseman LR, Adkins JC, Plosker GL,et al.Oxaliplatin a review of its use in the management of metastatic colorectal cancer[J].Drugs ＆ Aging,1999,14:459-475.
